Pfad >>

HAL Allergy

Logo Hal Allergy


HAL Allergy is one of the leading companies in the field of allergen diagnostic and immunotherapies in Europe. The allergy therapies are used against common allergies such as hay fever, house dust mites allergy and allergic reactions towards wasp or bee stings. The company works intensively in collaboration with its sales organizations, distributors and internationally acclaimed research institutes to bring out the best possible combination of knowledge and experience. The company focuses on the core group of allergy experts from the specialties of ENT, Dermatology and Pulmonology. HAL Allergy has the most modern and state-of-the-art production facility at its main site in the Bio Science Park at Leiden in the Netherlands. Currently their products are marketed in 16 countries. Moreover this leading manufacturer of therapeutic and diagnostic agents for allergies has sales organizations in all the major European markets including Germany, Poland, Austria, Italy and Spain.   


Leiden, Netherlands

Value enhancement strategy

  • Clinical Research – Europe-wide product approvals for the overall portfolio
  • R&D – Development of new immune therapies for respiratory and food allergens
  • Sales Force Excellence – Dealing with its core customer group through its own distribution company
  • Internationalisation – Focus on new markets - Asia, USA


Pharmaceutical Industry

Acquisition of share

December 2007


Management Team

HAL Allergy Group

Dr. Hans van Schijndel

Chief Research & Development Officer


HAL Allergy Group

Florian Rösch

Chief Commercial & Financial Officer


HAL Allergy Group

Dr. Eize de Boer

Chief Operations Officer


[Translate to Englisch:] Harry Flore, CEO HAL Allergy Group
Dr. Harry Flore, CEO HAL Allergy 

About HAL Allergy


Start video

News about Hal Allergy

back to top
WHAT WE DO Portfolio Hal Allergy